High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials

Archives of Internal Medicine

Volumn 170, Issue 9, 2010, Pages 751-758

  Wang, Chih Hung ^a   Ma, Matthew Huei Ming ^a   Chou, Hao Chang ^a   Yen, Zui Shen ^a   Yang, Chih Wei ^a   Fang, Cheng Chung ^a   Chen, Shyr Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG MEGADOSE; ENDOSCOPIC THERAPY; HUMAN; META ANALYSIS; MORTALITY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSCOPY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SURVIVAL RATE;

EID: 77952172715     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.100     Document Type: Review

References (45)

1. Viviane A, Alan BN. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008;11(1):1-3.
2. Lim CH, Vani D, Shah SG, Everett SM, Rembacken BJ. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy. 2006;38(6):581-585.
3. Barkun A, Sabbah S, Enns R, et al; RUGBE Investigators. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99(7):1238-1246.
4. Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology. 1992;102(1):139-148.
5. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006; 1(1):CD002094.
6. Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg. 1978;136(2):257-259. (Pubitemid 8406245)
7. Flatow FA Jr, Freireich EJ. The increased effectiveness of platelet concentrates prepared in acidified plasma. Blood. 1966;27(4):449-459.
8. Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74(1):38-43.
9. Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6(5):506-508.
10. Lanas A, Artal A, Blaś JM, Arroyo MT, Lopez-Zaborras J, Saínz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol. 1995;21(2):103-106.
11. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998; 158(1):54-58.
12. Hsu PI, Lo GH, Lo CC, et al. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol. 2004; 10(24):3666-3669.
13. Lin HJ, Lo WC, Cheng YC, Perng CL. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol. 2006;101(3):500-505.
14. Van Rensburg CJ, Thorpe A, Warren B, et al. Intragastric pH in patients with bleeding peptic ulceration during pantoprazole infusion of 8 mg/ hour [abstract]. Gut. 1997;41(suppl 3):A98.
15. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol. 1997;32 (4):320-327. (Pubitemid 27156168)
16. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: results of a placebo-controlled multicenter study. Scand J Gastroenterol. 1997;32(4):328-333.
17. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343(5):310-316.
18. Zargar SA, Javid G, Khan BA, et al. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial. J Gastroenterol Hepatol. 2006;21(4):716-721.
19. Leontiadis GI, Sharma VK, Howden CW. Systemic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005;330(7491):e568. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC554028/?tool= pubmed. Accessed February 9, 2010.
20. Sung JJY, Barkun A, Kuipers EJ, et al; Peptic Ulcer Bleed Study Group. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding. Ann Intern Med. 2009;150(7):455-464.
21. van Rensburg C, Barkun AN, Racz I, et al. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment Pharmacol Ther. 2009;29(5):497-507.
22. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci. 2005;50(7):1194-1201.
23. Hung WK, Li VK, Chung CK, et al. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. ANZ J Surg. 2007;77(8):677-681.
24. Andriulli A, Loperfido S, Focareta R, et al. High-versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.Am J Gastroenterol. 2008;103(12):3011-3018.
25. Yüksel I, Ataseven H, Köklü S, et al. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study. Digestion. 2008;78(1):39-43.
26. Yilmaz S, Bayan K, Tüzün Y, Dursun M, Canoruç F. A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots. World J Gastroenterol. 2006;12(48): 7837-7843. (Pubitemid 46099956)
27. Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized doubleblind study. Scand J Gastroenterol. 2001;36 (12):1332-1338.
28. Bajaj JS, Dua KS, Hanson K, Presberg K. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig Dis Sci. 2007;52(9):2190-2194. (Pubitemid 47246493)
29. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316-321. (Pubitemid 26074312)
30. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1):1-12. (Pubitemid 26120810)
31. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2(2):121-145.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
33. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement: Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896- 1900.
34. Dokas SM, Lazaraki GI, Kontoninas Z, et al. Bolus intravenous omeprazole b.i.d. vs. continuous intravenous omeprazole infusion combined with endoscopic hemostasis in the treatment of peptic ulcer bleeding. Preliminary results [abstract]. Gut. 2004;53(suppl 6):A290.
35. Schonekas H, Ahrens H, Ell C, et al. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding [abstract]. Gastroenterology. 1999;116:A305.
36. Garrido A, Giráldez A, Trigo C, Leo E, Guil A, Márquez JL. Intravenous proton-pump inhibitor for acute peptic ulcer bleeding: is profound acid suppression beneficial to reduce the risk of rebleeding [in Spanish]? Rev Esp Enferm Dig. 2008; 100(8):466-469.
37. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl JMed. 2008;359(9):928-937.
38. Lam SK, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut. 1980; 21(4):324-328. (Pubitemid 10056066)
39. Caraco Y, Lagerstrom PO, Wood AJJ. Ethnic and genetic determinants of omeprazole disposition and effect. Clin Pharmacol Ther. 1996;60(2): 157-167. (Pubitemid 26348230)
40. Caraco Y, Wilkinson GR, Wood AJJ. Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole. Clin Pharmacol Ther. 1996;60(4):396-404. (Pubitemid 26356001)
41. van Herwaarden MA, Samsom M, van Nispen CH, Mulder PG, Smout AJ. The effect of Helicobacter pylori eradication on intra-gastric pH during dosing with lansoprazole or ranitidine. Aliment Pharmacol Ther. 1999;13(6):731-740. (Pubitemid 29276841)
42. Simon-Rudler M, Massard J, Bernard-Chabert B, et al. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study. Aliment Pharmacol Ther. 2007;25(8):949-954. (Pubitemid 46525350)
43. Udd M, Töyry J, Miettinen P, Vanninen E, Mustonen H, Julkunen R. The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring. Eur J Gastroenterol Hepatol. 2005;17(12):1351-1356. (Pubitemid 41830457)
44. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut. 2002;51(suppl 4):iv1-iv6.
45. Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with non-variceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139(10):843-857.